Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma.

[1]  P. Watson,et al.  PD-L1 and intratumoral immune response in breast cancer. , 2017, Oncotarget.

[2]  R. Muschel,et al.  Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma , 2016, Oncotarget.

[3]  P. Watson,et al.  CD103 and Intratumoral Immune Response in Breast Cancer , 2016, Clinical Cancer Research.

[4]  H. Hollema,et al.  CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. , 2016, European journal of cancer.

[5]  Chun-tao Wu,et al.  Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma , 2016, The British journal of surgery.

[6]  Carsten Denkert,et al.  Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Jäger,et al.  Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma , 2015, British Journal of Cancer.

[8]  S. Endres,et al.  Analysis of FoxP3+ T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers , 2014, PloS one.

[9]  R. deLeeuw,et al.  Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer , 2013, Clinical Cancer Research.

[10]  A. Hinke,et al.  Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. , 2013, JAMA.

[11]  D. Lobo,et al.  The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays , 2013, BMC Cancer.

[12]  L. De Monte,et al.  Immune infiltrates as predictive markers of survival in pancreatic cancer patients , 2013, Front. Physiol..

[13]  Y. Kanai,et al.  Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer , 2013, British Journal of Cancer.

[14]  F. Mami-Chouaib,et al.  CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions. , 2013, Cancer research.

[15]  Carsten Denkert,et al.  Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization , 2012, PloS one.

[16]  A. Nowak,et al.  Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo , 2012, Cancer Immunology, Immunotherapy.

[17]  N. Jamieson,et al.  The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma , 2012, Annals of Surgical Oncology.

[18]  R. Hruban,et al.  Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas , 2011, Modern Pathology.

[19]  B. Nelson,et al.  Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer. , 2010, Gynecologic oncology.

[20]  T. Tani,et al.  A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients. , 2010, Oncology reports.

[21]  A. Dalgleish,et al.  Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses , 2009, British Journal of Cancer.

[22]  M. Werner,et al.  Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes , 2009, British Journal of Cancer.

[23]  A. Gemma,et al.  Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer , 2008, Cancer.

[24]  V. Lazar,et al.  αEβ7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis , 2007, The Journal of experimental medicine.

[25]  Peter Neuhaus,et al.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.

[26]  L. Zitvogel,et al.  Cancer despite immunosurveillance: immunoselection and immunosubversion , 2006, Nature Reviews Immunology.

[27]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[28]  B. Rasmussen,et al.  Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays , 2006, Journal of Clinical Pathology.

[29]  Z. Trajanoski,et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.

[30]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[31]  M. Büchler,et al.  Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  T. Oshikiri,et al.  CD8+ Tumor-Infiltrating Lymphocytes Together with CD4+ Tumor-Infiltrating Lymphocytes and Dendritic Cells Improve the Prognosis of Patients with Pancreatic Adenocarcinoma , 2004, Pancreas.

[33]  J. Frelinger,et al.  Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells1 , 2003, The Journal of Immunology.

[34]  J. Kirby,et al.  T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy? , 2002, British Journal of Cancer.

[35]  A. Nowak,et al.  Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. , 2002, Cancer research.

[36]  J. Kirby,et al.  Distribution of lymphocytes of the αEβ7 phenotype and E‐cadherin in normal human urothelium and bladder carcinomas , 2001 .

[37]  P. Schlag,et al.  Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. , 2001, Cancer research.

[38]  C. Cordon-Cardo,et al.  Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.

[39]  Morr.,et al.  Expression of mucosa‐related integrin αEβ7 on alveolar T cells in interstitial lung diseases , 1999 .

[40]  P. Malfertheiner,et al.  CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. , 1998 .

[41]  H Nagura,et al.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.

[42]  P. Malfertheiner,et al.  CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis* , 1998 .

[43]  Yih-Tai Chen,et al.  Direct and Regulated Interaction of Integrin αEβ7 with E-Cadherin , 1998, The Journal of cell biology.

[44]  P. Karecla,et al.  Recognition of E‐cadherin on epithelial cells by the mucosal T cell integrin αM290β7 (αEβ7) , 1995 .

[45]  D. Rimm,et al.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin , 1994, Nature.

[46]  D. Erle,et al.  Lung epithelial lining fluid T cell subsets defined by distinct patterns of beta 7 and beta 1 integrin expression. , 1994, American journal of respiratory cell and molecular biology.

[47]  J. J. Taylor,et al.  T-cell receptor heterogeneity of gamma delta T-cell clones from human female reproductive tissues. , 1993, Immunology.

[48]  P. Kilshaw,et al.  A new surface antigen on intraepithelial lymphocytes in the intestine , 1990, European journal of immunology.

[49]  K. Mizuno,et al.  Monoclonal Antibody , 2020, Definitions.

[50]  T. Greten,et al.  Immunological off-target effects of standard treatments in gastrointestinal cancers. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[52]  C. Lawton,et al.  Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer , 2012 .

[53]  Carsten Denkert,et al.  Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  D. Neal,et al.  Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas. , 2001, Clinical and experimental immunology.

[55]  W. Seeger,et al.  Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases. , 1999, Clinical and experimental immunology.

[56]  P. Karecla,et al.  Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). , 1995, European journal of immunology.

[57]  D. Rimm,et al.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. , 1994, Nature.

[58]  C. Griscelli,et al.  A monoclonal antibody (HML‐1) defining a novel membrane molecule present on human intestinal lymphocytes , 1987, European journal of immunology.